NEW YORK (Reuters Health) – Pooled clinical-trial data show that teprotumumab improves eye bulging and double vision in patients with
Read moreHome ยป
biologics
depo medrol farmaco
BEIJING (Reuters) – Chinese researchers are testing the mixing of COVID-19 vaccine doses developed by CanSino Biologics and a unit
Read moreCanSinoBIO Says No Serious Blood Clots From Its Vaccine
(Reuters) – China’s CanSino Biologics Inc said on Wednesday that no serious blood clot cases had been reported in people
Read morehow to buy cipro coupon without prescription
NEW YORK (Reuters Health) – Long-term glucocorticoid (GC) users see greater gains in spine bone-mineral density when treated with the
Read moreEU Investigating Teva for Blocking Rivals to Multiple Sclerosis Drug
BRUSSELS (Reuters) – Israeli drugmaker Teva is being investigated by EU antitrust regulators who are looking into whether it illegally
Read moreOver 60% of Russians Don’t Want Sputnik V Vaccine: Poll
MOSCOW (Reuters) – Nearly two thirds of Russians are not willing to receive Russia’s Sputnik V vaccine, and about the
Read morecheap voltaren coupons without prescription
NEW YORK (Reuters Health) – Following steroid withdrawal, the anti-CD20 monoclonal antibody rituximab is effective in maintaining long-term remission of
Read morehair loss using celexa
(Reuters) – British drugmaker GlaxoSmithKline Plc and Vir Biotechnology Inc will expand their existing partnership developing antibody therapies for COVID-19
Read more